Metraipolis › archive › dc_de8885671cfb

Radiotherapy-synergized in situ hydrogel vaccine with engineered Lactococcus lactis FOLactis potentiates anti-tumor immunity in pancreatic cancer — Europe PMC PMID:42445174

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42445174
DOI
10.3389/fimmu.2026.1789212
License (as archived)
solo-consultazione
Archived
2026-10-31T07:47:37.759Z
SHA-256 of the archived text
bf194f28b884717c71c1a74d70d9c85de63a3a1710f7e6c6cf90abe8773b8c85
Stable URL of this page
https://metraipolis.com/documento/dc_de8885671cfb

How to cite

Radiotherapy-synergized in situ hydrogel vaccine with engineered Lactococcus lactis FOLactis potentiates anti-tumor immunity in pancreatic cancer — Europe PMC PMID:42445174 — Europe PMC (en), https://europepmc.org/article/MED/42445174 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_de8885671cfb (Metraipolis archive dc_de8885671cfb, sha256 bf194f28b884717c71c1a74d70d9c85de63a3a1710f7e6c6cf90abe8773b8c85)
BibTeX
@misc{dcde8885671cfb,
  title = {Radiotherapy-synergized in situ hydrogel vaccine with engineered Lactococcus lactis FOLactis potentiates anti-tumor immunity in pancreatic cancer — Europe PMC PMID:42445174},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42445174},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_de8885671cfb; sha256 bf194f28b884717c71c1a74d70d9c85de63a3a1710f7e6c6cf90abe8773b8c85},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42445174. Agents can read the archived copy with the MCP tool read_document.